Informationen:
Fehler:
ID
13394
Beschreibung
Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT00712686
Link
https://clinicaltrials.gov/show/NCT00712686
Stichworte
Versionen (1)
- 10.02.16 10.02.16 -
Hochgeladen am
10. Februar 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Schizophrenia NCT00712686
Eligibility Schizophrenia NCT00712686
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Schizophrenia NCT00712686
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
schizophrenia relapse
Item
patients with dsm-iv diagnosis of schizophrenia patients in acute relapse
boolean
C0036341 (UMLS CUI [1,1])
C0277556 (UMLS CUI [1,2])
C0277556 (UMLS CUI [1,2])
outpatients
Item
treated as outpatients for at least one continuous 3-month period during the past 12 months
boolean
C0029921 (UMLS CUI [1])
panss score
Item
panss total score ≥60
boolean
C0451383 (UMLS CUI [1])
neuroleptics
Item
previously responsive to neuroleptics (other than clozapine)
boolean
C0040615 (UMLS CUI [1])
informed consent
Item
able to give informed consent and comprehend and satisfactorily comply with the protocol requirements
boolean
C0021430 (UMLS CUI [1])
schizoaffective disorder
Item
an axis i (dsm-iv) diagnosis of schizoaffective disorder
boolean
C0036337 (UMLS CUI [1])
mental disorders
Item
a clinical picture and/or history that was consistent with: (a) delirium, dementia, amnestic or other cognitive disorders; (b) bipolar disorder; (c)personality disorder
boolean
C0004936 (UMLS CUI [1])
olanzapine response
Item
nonresponsive to prior olanzapine therapy
boolean
C0171023 (UMLS CUI [1,1])
C1704632 (UMLS CUI [1,2])
C1704632 (UMLS CUI [1,2])
therapy
Item
likely to require prohibited concomitant therapy
boolean
C0087111 (UMLS CUI [1])
substance abuse
Item
dsm-iv criteria for any significant substance abuse within the past three months, including addiction to cocaine or alcohol
boolean
C0038586 (UMLS CUI [1])
hypersensitivity
Item
known to be allergic or hypersensitive to study drugs
boolean
C0020517 (UMLS CUI [1])
suicidal
Item
represented a significant risk of committing suicide based on history or mental status exam
boolean
C0438696 (UMLS CUI [1])
thyroid disease
Item
unstable thyroid pathology and treatment within the past six months
boolean
C0040128 (UMLS CUI [1])
comorbidity
Item
a history or evidence of a medical condition that would expose the patient to an undue risk
boolean
C0009488 (UMLS CUI [1])
health status
Item
clinically significant abnormal laboratory test results (including urine drug screen), vital sign, or ecg findings
boolean
C0018759 (UMLS CUI [1])